Speaker Details

Michael Tetzlaff, MD, PhD

Michael Tetzlaff, MD, PhD

SESSIONS

S031 Melanoma in 2027
Mar 20, 2027 • 1:00 PM - 4:00 PM
F053 A Primer and Practical Approach to Cancer Checkpoint Inhibitors for the Dermatologist
Mar 21, 2027 • 3:30 PM - 5:30 PM

DISCLOSURES

Merck – Other(Fees); Philogen S.p.A. – Advisory Board(Fees); Regeneron – Advisory Board(Honoraria);